We first told you about Lansing native Woody Ellis in September when he started his 2,000-mile journey across the country.

Improving environmental conditions and encouraging healthier lifestyles could help lower the cancer rates in New Jersey.

On March 1, 2024, the U.S. FDA approved RYBREVANT in combination with chemotherapy (carboplatin-pemetrexed) for the first-line treatment of patients with locally advanced or metastatic NSCLC with EGFR ...

In 2024, lung cancer is expected to account for 20% of cancer deaths, according to the National Cancer Institute. But ...

Researchers from Rice University and Baylor College of Medicine have demonstrated a groundbreaking treatment that eradicates ...

University of Bath and Edinburgh spin-out Prothea Technologies, which aims to offer lung cancer biopsy and treatment in a ...

NEW WILMINGTON, Pennsylvania (MyValleyTributes) – Carol Ann Headley, 85, of New Wilmington, Pennsylvania passed away in her home, holding hands with her son and daughter-in-law, on Tuesday, September ...

Johnson & Johnson said the Food and Drug Administration approved its treatment of locally-advanced or metastatic non-small cell lung cancer for adults. The treatment, called Rybrevant, has been ...

New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

Panelists discuss how the TROPION-Lung01 study results presented at World Conference on Lung Cancer 2024 shed light on ...

Panelists discuss how the SKIPPirr data outcomes presented at World Conference for Lung Cancer 2024 provide valuable insights into the potential use of amivantamab for advancing lung cancer treatment ...

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...